Daniel Koller: Three decades of biotech evolution

US still offering the most biotech names

clock • 4 min read

Over the past three decades, the biotech industry has witnessed remarkable growth and advances in drug development.

While 30-years ago biotechnology was a very young industry with a few dominant players such as Genentech, Amgen and Biogen, there is now a broad mix of large companies, start-ups and smaller providers with research and development candidates. European Assets appoints International Biotech trust chair to its board Then, as now, the US had the largest number of investable listed and private biotech companies and remains by far the most developed market for biotech investments today. Listed biotech companies in US and Europe today achieve revenues of over $200bn, which corresponds to ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment

Partner Insight: Broader scope can bring wider opportunity for decarbonisation investors

Partner Insight: Broader scope can bring wider opportunity for decarbonisation investors

In the journey toward a low carbon economy, Scope 4 emissions play a critical, but often overlooked role, says Raj Shant, managing director at Jennison Associates.

Sarka Halas
clock 22 July 2024 • 2 min read
Partner Insight: A dot-com lesson on diversification amid the AI boom

Partner Insight: A dot-com lesson on diversification amid the AI boom

Parallels between the dot-com bubble and today’s AI-driven market returns offer an important reminder about portfolio diversification.

Partner Insight: The Dividend Deluge

Partner Insight: The Dividend Deluge

Dividend investing has gained prominence, and it’s essential to navigate this golden period effectively.

Mark Peden, Investment Manager, Aegon Asset Management
clock 04 July 2024 • 6 min read
Trustpilot